New pill tested to help kids focus
NCT ID NCT07086313
Summary
This study is testing a new, once-daily capsule called EB-1020 to see if it can help control the core symptoms of ADHD in children and teenagers. It will compare two different doses of the medication against a placebo (a capsule with no active drug) over six weeks. The goal is to find out if the treatment is effective and safe for young patients with ADHD.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Hokkaido University Hospital
RECRUITINGSapporo, Japan
Conditions
Explore the condition pages connected to this study.